Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications
Pharmaceutics · 25.11.2023 · 15 (12) · 2671
DOI: 10.3390/pharmaceutics15122671 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 25.11.2023. Verfasst von Su Sundee Myint und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chulalongkorn University, Office of Academic Affairs, Chulalongkorn University, Second Century Fund (C2F), Chulalongkorn University.
Abstract (Originalsprache)
Hyaluronic acid (HA) nanogels are a versatile class of nanomaterials with specific properties, such as biocompatibility, hygroscopicity, and biodegradability. HA nanogels exhibit excellent colloidal stability and high encapsulation capacity, making them promising tools for a wide range of biomedical applications. HA nanogels can be fabricated using various methods, including polyelectrolyte complexation, self-assembly, and chemical crosslinking. The fabrication parameters can be tailored to control the physicochemical properties of HA nanogels, such as size, shape, surface charge, and porosity, enabling the rational design of HA nanogels for specific applications. Stimulus-responsive nanogels are a type of HA nanogels that can respond to external stimuli, such as pH, temperature, enzyme, and redox potential. This property allows the controlled release of encapsulated therapeutic agents in response to specific physiological conditions. HA nanogels can be engineered to encapsulate a variety of therapeutic agents, such as conventional drugs, genes, and proteins. They can then be delivered to target tissues with high efficiency. HA nanogels are still under development, but they have the potential to become powerful tools for a wide range of theranostic or solely therapeutic applications, including anticancer therapy, gene therapy, drug delivery, and bioimaging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence in Biomaterial Engineering in Medical and Health, Chulalongkorn University, Bangkok 10330, Thailand.
- Natural Products and Nanoparticles Research Unit (NP2), Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: Su Sundee Myint, Chavee Laomeephol, Sirikool Thamnium, Supakarn Chamni, Jittima Amie Luckanagul
Förderung
- Chulalongkorn University
- Office of Academic Affairs, Chulalongkorn University
- Second Century Fund (C2F), Chulalongkorn University
Zitieren
APA
Myint, S. S., Laomeephol, C., Thamnium, S., Chamni, S., & Luckanagul, J. A. (2023). Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications. Pharmaceutics, 15(12), 2671. https://doi.org/10.3390/pharmaceutics15122671
Vancouver
Myint SS, Laomeephol C, Thamnium S, Chamni S, Luckanagul JA. Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications. Pharmaceutics. 2023;15(12):2671. doi:10.3390/pharmaceutics15122671
BibTeX
@article{Myint2023,
author = {Myint, Su Sundee and Laomeephol, Chavee and Thamnium, Sirikool and Chamni, Supakarn and Luckanagul, Jittima Amie},
title = {Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {12},
pages = {2671},
doi = {10.3390/pharmaceutics15122671}
}
EUVIMED